Wilbe backs Europe’s scientists to become founders, minus red tape

Wilbe wants Europe’s scientists to build companies, not paperwork

Turning groundbreaking research into scalable companies remains a major challenge in Europe. Academic founders often face a maze of institutional rules, complex equity negotiations and limited exposure to investors. Wilbe, a London-based venture builder, is positioning itself as the missing bridge between Europe’s research labs and the startup ecosystem by stripping away the administrative burden that typically stalls scientific entrepreneurship.

A venture studio tailored to scientists, not serial founders

Unlike traditional accelerators that expect founders to arrive with a clear business model, Wilbe starts earlier in the journey. The firm works directly with researchers, postdocs and principal investigators to identify commercially viable applications for their work, then helps them form companies while protecting their scientific focus.

The model combines a structured venture-building program with hands-on legal, regulatory and fundraising support. By standardising incorporation, equity frameworks and IP agreements, Wilbe aims to remove the layers of red tape that often deter scientists from leaving academia or spinning out a company from their institution.

Solving Europe’s spinout and IP bottlenecks

One of the biggest friction points in Europe is the way universities handle intellectual property and equity in spinouts. Negotiations can take months, sometimes years, and often result in structures that are unattractive to investors. Wilbe is building repeatable templates for IP licensing, founder equity and university participation that can be deployed quickly and adapted across jurisdictions.

This approach is designed to make deep-tech and life-science ventures more compatible with venture capital expectations, while giving researchers confidence that their contributions are recognised fairly. By aligning incentives early, the firm hopes to accelerate the path from lab result to seed round.

Integrated support: from lab bench to boardroom

Beyond legal and IP support, Wilbe embeds operational expertise around company formation, regulatory strategy and early commercialisation. Scientists are paired with experienced operators and advisors who understand fundraising, go-to-market strategy and scaling teams.

The ambition is clear: create a repeatable, low-friction pathway for Europe’s top researchers to become venture-ready founders, without forcing them to navigate fragmented national regulations or opaque university processes on their own.

Positioning Europe for the next wave of deep-tech innovation

Europe’s universities and institutes produce world-class research in areas such as quantum technologies, biotech, climate tech and advanced materials. Yet many breakthroughs never leave the lab. By systematising company creation and lowering administrative barriers, Wilbe is betting that the continent can unlock a new generation of science-driven startups that compete globally from day one.